Skip to main content

Animations

MJFF Publications

1551 - 1560 of 6082 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Leveraging Patient Preference Information in Medical Device Clinical Trial Design
    Journal Name: Therapeutic Innovation & Regulatory Science
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s43441-022-00450-9
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.977985
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: a prospective study
    Journal Name: Journal of Clinical Sleep Medicine
    Publisher: American Academy of Sleep Medicine (AASM)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.5664/jcsm.10268
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201159
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23179639
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Beyond ATP, new roles of mitochondria
    Journal Name: The Biochemist
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1042/bio_2022_119
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29164
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson’s disease
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702221117147
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.994114
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.